Brokerages Set TG Therapeutics, Inc. (NASDAQ:TGTX) Target Price at $40.80
TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the five research firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year price objective […]
TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the five research firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year price objective […]
